CME webinar series: Empowering Providers on Substance Use Disorders

Jun. 2025Education/Webinars

Register for our new CME webinar series: Empowering Providers on Substance Use Disorders

Join us for our upcoming CME webinar series, "Empowering Providers," designed to enhance your knowledge and skills in managing substance use disorders. This four-part series will provide you with the latest insights and evidence-based strategies to improve patient outcomes.

Overdose Prevention and Response Training

  • Join us on Aug. 26, 2025, from noon to 1 p.m., to learn how to recognize overdose risks and symptoms, respond effectively, and apply proven strategies to prevent patient overdose.

    Comprehensive Care for Alcohol Use Disorder

  • Join us on Sept. 9, 2025, from noon to 1 p.m., to explore the importance of screening for alcohol use disorder (AUD), learn how to use effective screening tools, and apply evidence-based treatment strategies to improve patient care.

    Comprehensive Care for Opioid Use Disorder

  • Join us on Sept. 30, 2025, from noon to 1 p.m., to explore the importance of screening for opioid use disorder (OUD), learn how to use effective screening tools, and implement evidence-based treatments to support recovery.

    Comprehensive Care for Tobacco Use Disorder

  • Join us on Nov. 12, 2025, from noon to 1 p.m., to learn how to recognize tobacco use disorder (TUD), use proven screening tools, and deliver evidence-based care to help patients quit tobacco successfully.

Register Now

Provider is responsible for verifying CME eligibility.

This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, ACPE, and ASWB. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.


Recent Announcements

Voluntary nationwide recall: Sulfamethoxazole/Trimethoprim (Amneal – June)

Amneal Pharmaceutical LLC is recalling certain lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg. Sulfamethoxazole/Trimethoprim is used for the treatment of certain bacterial infections.
Jun. 2025Pharmacy Updates

Voluntary nationwide recall: Sulfamethoxazole/Trimethoprim (Amneal – June)

Amneal Pharmaceutical LLC is recalling certain lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg. Sulfamethoxazole/Trimethoprim is used for the treatment of certain bacterial infections.
Jun. 2025Pharmacy Updates

Important update: Rite Aid pharmacy closures and patient transition support

The closure of Rite Aid pharmacy locations may significantly impact UPMC Health Plan members’ ability to access their medications in a timely manner.
Jun. 2025Important Notices